Pfizer Lilly: Different Bets on Pharma M&A Explained
Eli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
This section highlights volatility metrics for the dividend aristocrats ETF, offering key indicators to monitor risk and potential entry points.
22,062 articlesEli Lilly posts a blockbuster start to 2026 as Pfizer works to rebuild after the COVID era, highlighting pfizer lilly...
The Devil Wears Prada 2 narrowly leads the box office over mortal kombat ii in North America this weekend, signaling ...
Halozyme’s halo (HALO) 2026 earnings landscape hinges on ENHANZE collaborations, pipeline milestones, and disciplined...
Wells Fargo lifts its NVIDIA price target to $315 ahead of the May earnings release, maintaining an Overweight rating...
A majority of parents are now including teens in financial talks with advisors, signaling a broader move toward famil...
A bold NYC budget claim sparks debate about deficits and government finance. Learn how the idea of a zero-based, bala...
March 2026 BEA data shows u.s. consumer spending tops $21.86 trillion, underscoring broad demand. A select group of f...
As negotiators in Beijing steer talks between the U.S. and China, investors are eyeing three names likely to move: NV...
Brokerage mergers are reshaping the mortgage landscape as Compass International Holdings, Real, and eXp expand their ...
The internet computer (icp) tumbles about 10% in a broad crypto selloff, weakening after Coinbase removed several ICP...
As Congress debates a sweeping housing bill, lenders and manufacturers warn about misaligned incentives. This opinion...
Tech chipmakers pull back Friday after a brisk rally, with Intel leading declines and Nvidia slipping ahead of earnings.